Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma Our study included a broad cohort of ...
The Consumer Technology Association (CTA) has released a new artificial intelligence standard that requires model developers to meet specific accuracy and explainability requirements for pre-market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback